(D-Cys(tBu)2,Thr(tBu)6)-Leu-Enkephalin-Thr is a modified enkephalin peptide with t-butyl cysteine and threonine substitutions to increase its stability and protect it from enzymatic degradation. The peptide is used in studies of opioid receptor interaction, specifically in pain modulation and neurotransmitter release. Researchers use it to explore the role of enkephalin analogs in the regulation of the central nervous system.
1. The spatiotemporal control of signalling and trafficking of the GLP-1R
3. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors
4. Cationic cell-penetrating peptides are potent furin inhibitors
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More